| __timestamp | BioCryst Pharmaceuticals, Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 13486000 | 1256834000000 |
| Thursday, January 1, 2015 | 46361000 | 1271973000000 |
| Friday, January 1, 2016 | 23654000 | 1173296000000 |
| Sunday, January 1, 2017 | 23484000 | 1274610000000 |
| Monday, January 1, 2018 | 20182000 | 1437534000000 |
| Tuesday, January 1, 2019 | 44734000 | 2201424000000 |
| Wednesday, January 1, 2020 | 16136000 | 2203504000000 |
| Friday, January 1, 2021 | 149906000 | 2462160000000 |
| Saturday, January 1, 2022 | 264233000 | 2783406000000 |
| Sunday, January 1, 2023 | 326751000 | 2832257000000 |
| Monday, January 1, 2024 | 2832257000000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical industry, understanding financial trends is crucial. This analysis compares the gross profit trajectories of Takeda Pharmaceutical Company Limited and BioCryst Pharmaceuticals, Inc. over the past decade. Takeda, a Japanese multinational, consistently demonstrates robust financial health, with gross profits soaring from approximately 1.26 trillion in 2014 to an impressive 2.83 trillion in 2023. This represents a remarkable growth of over 125%.
Conversely, BioCryst, a smaller American biotech firm, shows a more volatile yet promising trend. From a modest 13.5 million in 2014, its gross profit surged to 327 million by 2023, marking an exponential increase of over 2300%. Despite missing data for 2024, these trends highlight the contrasting scales and growth dynamics of these two companies, offering valuable insights into their strategic positioning in the global market.
Bristol-Myers Squibb Company and Takeda Pharmaceutical Company Limited: A Detailed Gross Profit Analysis
Takeda Pharmaceutical Company Limited and Incyte Corporation: A Detailed Gross Profit Analysis
Gross Profit Trends Compared: Takeda Pharmaceutical Company Limited vs Walgreens Boots Alliance, Inc.
Takeda Pharmaceutical Company Limited vs Vericel Corporation: A Gross Profit Performance Breakdown
Takeda Pharmaceutical Company Limited vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Comparison: Takeda Pharmaceutical Company Limited and Amphastar Pharmaceuticals, Inc. Trends
Who Optimizes SG&A Costs Better? Takeda Pharmaceutical Company Limited or BioCryst Pharmaceuticals, Inc.
Key Insights on Gross Profit: Jazz Pharmaceuticals plc vs BioCryst Pharmaceuticals, Inc.
Who Generates Higher Gross Profit? Pharming Group N.V. or BioCryst Pharmaceuticals, Inc.
Gross Profit Trends Compared: Grifols, S.A. vs BioCryst Pharmaceuticals, Inc.
Who Generates Higher Gross Profit? Ligand Pharmaceuticals Incorporated or BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. vs MiMedx Group, Inc.: A Gross Profit Performance Breakdown